Empiece
BADQOMOCAWGOWLD

$OCGN Ocugen Inc Long term PTs 16 - 21 - 180 and higher

Largo
Ocugen, Inc. (BATS:OCGN)  
BADQOMOCAWGOWLD  
BATS:OCGN   Ocugen, Inc.
Harmonic Patterns Chart Patterns Technical Indicators Contains IO script
2
2
harmonicpatterns chartpattern indicator containsioscript
OCGN Ocugen Inc
Long term PTs 16 - 21 - 180 and higher

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 and OCU410ST for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. It has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.